Home | Publications | Treatments | Analgesics place holder
place holder place holder

Analgesics


Analgesics in Ireland


Publication Date   August 2007
Publisher   Euromonitor International
Product Type   Report
Pages   33
ISBN Number   not applicable
Product Code   EUR689
Ask a question about this product?

Price £450.00

approximately: $671 | €536

Summary


Euromonitor International's Analgesics in Ireland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2001-2006), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2011 illustrate how the market is set to change.

Product coverage: adult analgesics, child-specific analgesics, systemic analgesics, topical analgesics

Data coverage: market sizes (historic and forecasts), company shares, brand shares

Why buy this report?

  • Get a detailed picture of the analgesics industry
  • Pinpoint growth sectors and trends and identify factors driving change
  • Understand the competitive environment, the market's major players and leading brands
  • Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore and Shanghai and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning.

Content


OTC Healthcare - Australia

OTC Healthcare in Australia : Market Insight

EXECUTIVE SUMMARY
Slow but favourable growth Vitamins and dietary supplements still the biggest OTC healthcare sector Symbion Health Ltd the leader in OTC healthcare Private label affecting OTC healthcare sales Steady but not spectacular forecast period performance expected KEY TRENDS AND DEVELOPMENTS
Expansion of pharmacy banner groups Drivers of OTC healthcare innovation products Merger and acquisition focus for expansion Direct sellers/Internet to change the face of OTC healthcare PBS reform to lower the prices of medicines for patients Illnesses related to stress and bad diet MARKET INDICATORS
Table 1 Life Expectancy at Birth 2001-2006
MARKET DATA
Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 4 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 5 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 6 Penetration of Private Label by Sector 2002-2006
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
APPENDIX
OTC Registration and Classification Vitamins and Dietary Supplements Registration and Classification Generics Consumer Expenditure on Health Goods and Medical Services
Table 11 Consumer Expenditure on Health Goods and Medical Services 2001-2006
DEFINITIONS
Sources
Summary 1 Research Sources

Local Company Profiles - Australia

Australian Pharmaceutical Industries Ltd - OTC Healthcare - Australia
STRATEGIC DIRECTION KEY FACTS
Summary 2 Australian Pharmaceutical Industries Ltd: Key Facts
Summary 3 Australian Pharmaceutical Industries Ltd: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING Blackmores Ltd - OTC Healthcare - Australia
STRATEGIC DIRECTION KEY FACTS
Summary 4 Blackmores Ltd: Key Facts
Summary 5 Blackmores Ltd: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 6 Blackmores Ltd: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 7 Blackmores Ltd: Competitive Position 2006
Mannatech Australia Pty Ltd - OTC Healthcare - Australia
STRATEGIC DIRECTION KEY FACTS
Summary 8 Mannatech Australia Pty Ltd: Key Facts
Summary 9 Mannatech Australia Pty Ltd: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 10 Mannatech Australia Pty Ltd: Competitive Position 2006
Sigma Pharmaceuticals Ltd - OTC Healthcare - Australia
STRATEGIC DIRECTION KEY FACTS
Summary 11 Sigma Pharmaceuticals Pty Ltd: Key Facts
Summary 12 Sigma Pharmaceuticals Pty Ltd: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 13 Sigma Pharmaceuticals Pty Ltd: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 14 Sigma Pharmaceuticals Pty Ltd: Competitive Position 2006
Symbion Health Ltd - OTC Healthcare - Australia
STRATEGIC DIRECTION KEY FACTS
Summary 15 Symbion Health Ltd: Key Facts
Summary 16 Symbion Health Ltd: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 17 Symbion Health Ltd: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 18 Symbion Health Ltd: Competitive Position 2006

Wound treatments in Australia

OVERVIEW
SECTOR DATA
Table 12 Sales of Wound Treatments by Subsector: Value 2001-2006
Table 13 Sales of Wound Treatments by Subsector: % Value Growth 2001-2006
Table 14 Wound Treatments Company Shares by Retail Value 2002-2006
Table 15 Wound Treatments Brand Shares by Retail Value 2003-2006
Table 16 Forecast Sales of Wound Treatments by Subsector: Value 2006-2011
Table 17 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2006-2011